Skip to main content

Infarct related culprit Versus Non- culprit vessel revascularization


Infarct related culprit Vs. non- culprit vessel revascularization

A 38 year old male smoker and hypertensive presented with severe retrosternal chest pain of 3 hours duration. On examination he was hypertensive with BP = 80/50 sinus bradycardia with HR 40bpm, right sided S3 and chest clear. He recently underwent primary PCI to LAD a month ago, coronary angiogram at that time revealed LAD 90% stenosis, LCX mid 50% stenosis, RCA proximal 60-70% stenosis and Right PDA has 80% osteal stenosis. 

ECG on current presentation showed sinus bradycardia and ST depressions more than 2mm in inferior leads. Please give answer of following questions based on guidelines
a)      Is TPM indicated, if yes then give justification
b)      Name the culprit vessel
c)      Do you think revascularization of non-culprit vessel at time of primary PCI would have prevented current cardiac event
d)      Name the trials which have studied such scenarios



Answers:

a. Yes, Symptomatic bradycardia
b. RCA/PDA
c. Yes
d. DANAMI, PRAGUE, CULPRIT and PRAMI Trail (Infarct related culprit Vs. non- culprit vessel revascularization)

Reference:

1.      Chapter 22, page 390 – Bradyarrythmias - Manual of Cardiovascular Medicine Fourth Edition - Brian P. Griffin MD FACC

2.      Engstrom T, Kelbaek H, Helqvist S, et al. Complete revascularization versus treatment of the culprit lesion only in patients with ST segment elevation myocardial infarction and multi vessel disease (DANAMI 3- PRIMULTI) an open – label randomized controlled trial. Lancet 2015;386:665-71.10.1016/S0140-6736(15)60648-1 [Pubmed]

Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...